|
TRMT11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61477999999216E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.371500E-04 |
| Normal-vs-Stage2 |
2.582100E-02 |
| Normal-vs-Stage3 |
5.245600E-02 |
| Normal-vs-Stage4 |
5.155700E-02 |
| Stage1-vs-Stage2 |
8.435800E-01 |
| Stage1-vs-Stage3 |
5.391600E-01 |
| Stage1-vs-Stage4 |
8.110000E-01 |
| Stage2-vs-Stage3 |
4.874600E-01 |
| Stage2-vs-Stage4 |
7.056800E-01 |
| Stage3-vs-Stage4 |
8.619000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.76500000001767E-06 |
| Normal-vs-AfricanAmerican |
5.604200E-03 |
| Normal-vs-Asian |
6.235000E-01 |
| Caucasian-vs-AfricanAmerican |
4.083400E-01 |
| Caucasian-vs-Asian |
3.128200E-01 |
| AfricanAmerican-vs-Asian |
4.399600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56798999999541E-05 |
| Normal-vs-Female |
3.240200E-03 |
| Male-vs-Female |
6.593400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.611900E-02 |
| Normal-vs-Extreme_Weight |
2.980600E-04 |
| Normal-vs-Obese |
2.373100E-04 |
| Normal-vs-Extreme_Obese |
2.853400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.116600E-01 |
| Normal_Weight-vs-Obese |
2.115800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.545400E-01 |
| Extreme_Weight-vs-Obese |
7.533200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.094200E-01 |
| Obese-vs-Extreme_Obese |
5.969800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.341100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.26280000001255E-06 |
| Normal-vs-Age(61-80Yrs) |
1.159710E-03 |
| Normal-vs-Age(81-100Yrs) |
3.569800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.768400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.916600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.159200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.115800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.086100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.754200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.22320000373844E-08 |
| Normal-VS-Type2 PRCC |
2.184100E-02 |
| Normal-VS-KIRP CIMP |
5.268500E-02 |
| Normal-VS-Unclassified PRCC |
1.105750E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.709640E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.972200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.205900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.310200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.244000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.285200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.235990E-01 |
| Normal-vs-N1 |
1.199760E-03 |
| Normal-vs-N2 |
9.233800E-01 |
| N0-vs-N1 |
1.426600E-01 |
| N0-vs-N2 |
7.295800E-01 |
| N1-vs-N2 |
5.628600E-01 |
|
|
